Butyrate reduces high-fat diet-induced metabolic alterations, hepatic steatosis and pancreatic beta cell and intestinal barrier dysfunctions in prediabetic mice
V. A. Matheus, L. C. S. Monteiro, R. B. Oliveira, D. A. Maschio, C. B. Collares-Buzato
ARTIGO
Inglês
In this study, we investigated the effect of diet supplementation with sodium butyrate (5% w/w), a short-chain fatty acid produced by the intestinal microbiota, on metabolic parameters, body adiposity, hepatic and pancreatic lipid accumulation, beta cell
CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO - CNPQ
304991/2015-5
FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO - FAPESP
2013/15676-0
fechado
Butyrate reduces high-fat diet-induced metabolic alterations, hepatic steatosis and pancreatic beta cell and intestinal barrier dysfunctions in prediabetic mice
V. A. Matheus, L. C. S. Monteiro, R. B. Oliveira, D. A. Maschio, C. B. Collares-Buzato
Butyrate reduces high-fat diet-induced metabolic alterations, hepatic steatosis and pancreatic beta cell and intestinal barrier dysfunctions in prediabetic mice
V. A. Matheus, L. C. S. Monteiro, R. B. Oliveira, D. A. Maschio, C. B. Collares-Buzato
Fontes
|
Experimental biology and medicine Vol. 242, no. 12 (June, 2017), p. 1214-1226 |